Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor. —In an article published in the Archives (1979;139:196-197), DeBard reported for the first time, to his knowledge, three cases of a secondary reaction mimicking septic shock after methyldopa administration. The symptoms—fever, collapse, vomiting, and abdominal pains—were accompanied by a slight increase of blood azotemia and by a hyperleukocytosis of the polynuclear type. This iatrogenic complication occurred 14 days after beginning the methyldopa treatment and was observed in three female patients older than 70 years. Report of a Case. —A similar case was seen by us in a 70-year-old man treated for 12 days with methyldopa, 250 mg/day, to reduce high blood pressure. This man was febrile (40 °C), suffered from violent lumbar pains, and was initially seen with a deep asthenia accompanied by complete impotency of the legs and mental confusion. The WBC count was 11,900 leukocytes with 96% of neutrophilic polynuclear form and 2% lymphocytes.
Archives of Internal Medicine – American Medical Association
Published: Aug 1, 1981
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.